Accounting and consulting firm Deloitte released its 2023 Technology Fast 500 list, ranking the fastest-growing technology and life sciences companies in North America. The 29th annual list featured 96 San Francisco companies. Last year’s list featured 100 companies from the Bay Area.
Companies on the list were chosen based on their fiscal year revenue growth between 2019 and 2022 and ranked based on their percentage growth rate. The technology sector, as well as the media, telecommunications, life sciences, fintech and energy tech industries, are represented on the list.
“The Bay Area continues to be the engine behind innovation,” Carina Ruiz, Silicon Valley managing partner at Deloitte, said in a statement. “There’s truly no better place to create and defy the status quo than in San Francisco and Silicon Valley. With the largest number of companies recognized in this year’s Fast 500 once again, the Bay Area is positioned to continue to play an instrumental role in creating a more innovative and sustainable future.”
Read on below for details on the top five San Francisco-based tech companies included in this year’s Deloitte ranking and be sure to check out the full list.
Top SF Tech Companies on Deloitte’s 2023 Technology Fast 500
- Vir Biotechnology, Inc.
- Seer, Inc.
- Protagonist Therapeutics, Inc.
- Turing
- Productiv, Inc.
Rank #31, 5,631% Growth
Headquartered in Palo Alto, Productiv’s spend management solution leverages company data to help organizations procure, manage and renew software. The solution integrates with an organization’s core operating systems to use data and AI to empower collaboration and help companies make adjustments with scalable no-code workflows. Back in May, the company announced the addition of a new chief product officer to its team.
Rank #23, 8,054% Growth
Hiring tech platform Turing uses AI to connect its vetted network of vetted developers and engineering team companies, working to help them achieve their respective career and business goals. The company launched its Turing Services offering earlier this year.
Rank #16, 11,407% Growth
Newark-based biotech company Protagonist is focused on discovering and developing peptide-based new chemical entities with the goal of helping meet unmet needs across rare and prevalent diseases that currently have limited or inadequate treatment options.
Rank #5, 26,095% Growth
Headquartered in Redwood City, Seer is a biotech company works to provide the scientific community with the tools needed for studying the proteome, or the proteins and cells or tissues. Helping companies optimize their proteomics research, Seer’s platform helps scientists leverage unbiased coverage, deep access to a range of proteins, expedited workflow and scalable technology.
Rank #1, 222,189% Growth
Having seen an exponential amount of growth, Vir Biotechnology topped Deloitte’s list for the fastest-growing North American company again this year. Vir focuses on powering the immune system to address unmet patient needs in the infectious disease sector. Its current clinical pipeline includes therapy candidates for hepatitis B and hepatitis delta viruses, as well as human immunodeficiency virus, or HIV.
